Cellular insulin resistance in Epstein-Barr virus-transformed lymphoblasts from young insulin-resistant Japanese men

Toshiyuki Morii, Yoichi Ohno, Hiroshi Hirose, Hiroshi Kawabe, Tsutomu Ogata, Keiichi Hirao, Takashi Eguchi, Tatsuya Maruyama, Yoshihiko Kanno, Matsuhiko Hayashi, Ikuo Saito, Takao Saruta

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The metabolic syndrome is characterized by a blunted insulin-mediated glucose uptake in various cell types. We compared the glucose uptake characteristics of Epstein-Barr virus (EBV)-transformed lymphoblasts obtained from young men with vs without metabolic and cardiovascular evidence of metabolic syndrome. From a population of 218 men, 20- to 25-year-old, 10 men with a systolic blood pressure (BP) ≥130 mm Hg and family history of hypertension were assigned to a high BP (HBP) group, and 10 with a BP ≤110 mm Hg, and no family history of hypertension was assigned to a low BP (LBP) group. Multiple clinical and metabolic characteristics were examined in both groups and compared. Peripheral lymphocytes from HBP and LBP subjects were EBV-transformed, and the glucose transporter (Glut)-mediated glucose uptake from each group was compared in lymphoblasts. Body mass index, fasting glucose, immunoreactive insulin, insulin resistance index based on a homeostasis model assessment (HOMA-R), and total and low-density lipoprotein cholesterol were significantly higher in the HBP than the LBP subgroup (whole-body insulin resistance). Baseline Glut-mediated and Glut-mediated insulin-stimulated glucose uptake by lymphoblasts from the HBP group were significantly lower than by lymphoblasts from the LBP group (cellular insulin resistance). The net increment in Glut-mediated glucose uptake by insulin was inversely correlated with HOMA-R. In conclusion, cellular insulin resistance in EBV-transformed lymphoblasts is associated with young Japanese subjects with HBP. The net increment in Glut-mediated glucose uptake by insulin in lymphoblasts may be a useful intermediate phenotype to study genetic aspects of the metabolic syndrome.

Original languageEnglish
Pages (from-to)370-375
Number of pages6
JournalMetabolism: Clinical and Experimental
Volume54
Issue number3
DOIs
Publication statusPublished - 2005 Mar

Fingerprint

Human Herpesvirus 4
Insulin Resistance
Facilitative Glucose Transport Proteins
Insulin
Glucose
Blood Group Antigens
Blood Pressure
Hypertension
Metabolic Syndrome X
Hypotension
LDL Cholesterol
Fasting
Body Mass Index
Homeostasis
Lymphocytes
Phenotype
Population

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Cellular insulin resistance in Epstein-Barr virus-transformed lymphoblasts from young insulin-resistant Japanese men. / Morii, Toshiyuki; Ohno, Yoichi; Hirose, Hiroshi; Kawabe, Hiroshi; Ogata, Tsutomu; Hirao, Keiichi; Eguchi, Takashi; Maruyama, Tatsuya; Kanno, Yoshihiko; Hayashi, Matsuhiko; Saito, Ikuo; Saruta, Takao.

In: Metabolism: Clinical and Experimental, Vol. 54, No. 3, 03.2005, p. 370-375.

Research output: Contribution to journalArticle

Morii, T, Ohno, Y, Hirose, H, Kawabe, H, Ogata, T, Hirao, K, Eguchi, T, Maruyama, T, Kanno, Y, Hayashi, M, Saito, I & Saruta, T 2005, 'Cellular insulin resistance in Epstein-Barr virus-transformed lymphoblasts from young insulin-resistant Japanese men', Metabolism: Clinical and Experimental, vol. 54, no. 3, pp. 370-375. https://doi.org/10.1016/j.metabol.2004.10.003
Morii, Toshiyuki ; Ohno, Yoichi ; Hirose, Hiroshi ; Kawabe, Hiroshi ; Ogata, Tsutomu ; Hirao, Keiichi ; Eguchi, Takashi ; Maruyama, Tatsuya ; Kanno, Yoshihiko ; Hayashi, Matsuhiko ; Saito, Ikuo ; Saruta, Takao. / Cellular insulin resistance in Epstein-Barr virus-transformed lymphoblasts from young insulin-resistant Japanese men. In: Metabolism: Clinical and Experimental. 2005 ; Vol. 54, No. 3. pp. 370-375.
@article{aa34aee07f4940baac8104c72f12ef8f,
title = "Cellular insulin resistance in Epstein-Barr virus-transformed lymphoblasts from young insulin-resistant Japanese men",
abstract = "The metabolic syndrome is characterized by a blunted insulin-mediated glucose uptake in various cell types. We compared the glucose uptake characteristics of Epstein-Barr virus (EBV)-transformed lymphoblasts obtained from young men with vs without metabolic and cardiovascular evidence of metabolic syndrome. From a population of 218 men, 20- to 25-year-old, 10 men with a systolic blood pressure (BP) ≥130 mm Hg and family history of hypertension were assigned to a high BP (HBP) group, and 10 with a BP ≤110 mm Hg, and no family history of hypertension was assigned to a low BP (LBP) group. Multiple clinical and metabolic characteristics were examined in both groups and compared. Peripheral lymphocytes from HBP and LBP subjects were EBV-transformed, and the glucose transporter (Glut)-mediated glucose uptake from each group was compared in lymphoblasts. Body mass index, fasting glucose, immunoreactive insulin, insulin resistance index based on a homeostasis model assessment (HOMA-R), and total and low-density lipoprotein cholesterol were significantly higher in the HBP than the LBP subgroup (whole-body insulin resistance). Baseline Glut-mediated and Glut-mediated insulin-stimulated glucose uptake by lymphoblasts from the HBP group were significantly lower than by lymphoblasts from the LBP group (cellular insulin resistance). The net increment in Glut-mediated glucose uptake by insulin was inversely correlated with HOMA-R. In conclusion, cellular insulin resistance in EBV-transformed lymphoblasts is associated with young Japanese subjects with HBP. The net increment in Glut-mediated glucose uptake by insulin in lymphoblasts may be a useful intermediate phenotype to study genetic aspects of the metabolic syndrome.",
author = "Toshiyuki Morii and Yoichi Ohno and Hiroshi Hirose and Hiroshi Kawabe and Tsutomu Ogata and Keiichi Hirao and Takashi Eguchi and Tatsuya Maruyama and Yoshihiko Kanno and Matsuhiko Hayashi and Ikuo Saito and Takao Saruta",
year = "2005",
month = "3",
doi = "10.1016/j.metabol.2004.10.003",
language = "English",
volume = "54",
pages = "370--375",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Cellular insulin resistance in Epstein-Barr virus-transformed lymphoblasts from young insulin-resistant Japanese men

AU - Morii, Toshiyuki

AU - Ohno, Yoichi

AU - Hirose, Hiroshi

AU - Kawabe, Hiroshi

AU - Ogata, Tsutomu

AU - Hirao, Keiichi

AU - Eguchi, Takashi

AU - Maruyama, Tatsuya

AU - Kanno, Yoshihiko

AU - Hayashi, Matsuhiko

AU - Saito, Ikuo

AU - Saruta, Takao

PY - 2005/3

Y1 - 2005/3

N2 - The metabolic syndrome is characterized by a blunted insulin-mediated glucose uptake in various cell types. We compared the glucose uptake characteristics of Epstein-Barr virus (EBV)-transformed lymphoblasts obtained from young men with vs without metabolic and cardiovascular evidence of metabolic syndrome. From a population of 218 men, 20- to 25-year-old, 10 men with a systolic blood pressure (BP) ≥130 mm Hg and family history of hypertension were assigned to a high BP (HBP) group, and 10 with a BP ≤110 mm Hg, and no family history of hypertension was assigned to a low BP (LBP) group. Multiple clinical and metabolic characteristics were examined in both groups and compared. Peripheral lymphocytes from HBP and LBP subjects were EBV-transformed, and the glucose transporter (Glut)-mediated glucose uptake from each group was compared in lymphoblasts. Body mass index, fasting glucose, immunoreactive insulin, insulin resistance index based on a homeostasis model assessment (HOMA-R), and total and low-density lipoprotein cholesterol were significantly higher in the HBP than the LBP subgroup (whole-body insulin resistance). Baseline Glut-mediated and Glut-mediated insulin-stimulated glucose uptake by lymphoblasts from the HBP group were significantly lower than by lymphoblasts from the LBP group (cellular insulin resistance). The net increment in Glut-mediated glucose uptake by insulin was inversely correlated with HOMA-R. In conclusion, cellular insulin resistance in EBV-transformed lymphoblasts is associated with young Japanese subjects with HBP. The net increment in Glut-mediated glucose uptake by insulin in lymphoblasts may be a useful intermediate phenotype to study genetic aspects of the metabolic syndrome.

AB - The metabolic syndrome is characterized by a blunted insulin-mediated glucose uptake in various cell types. We compared the glucose uptake characteristics of Epstein-Barr virus (EBV)-transformed lymphoblasts obtained from young men with vs without metabolic and cardiovascular evidence of metabolic syndrome. From a population of 218 men, 20- to 25-year-old, 10 men with a systolic blood pressure (BP) ≥130 mm Hg and family history of hypertension were assigned to a high BP (HBP) group, and 10 with a BP ≤110 mm Hg, and no family history of hypertension was assigned to a low BP (LBP) group. Multiple clinical and metabolic characteristics were examined in both groups and compared. Peripheral lymphocytes from HBP and LBP subjects were EBV-transformed, and the glucose transporter (Glut)-mediated glucose uptake from each group was compared in lymphoblasts. Body mass index, fasting glucose, immunoreactive insulin, insulin resistance index based on a homeostasis model assessment (HOMA-R), and total and low-density lipoprotein cholesterol were significantly higher in the HBP than the LBP subgroup (whole-body insulin resistance). Baseline Glut-mediated and Glut-mediated insulin-stimulated glucose uptake by lymphoblasts from the HBP group were significantly lower than by lymphoblasts from the LBP group (cellular insulin resistance). The net increment in Glut-mediated glucose uptake by insulin was inversely correlated with HOMA-R. In conclusion, cellular insulin resistance in EBV-transformed lymphoblasts is associated with young Japanese subjects with HBP. The net increment in Glut-mediated glucose uptake by insulin in lymphoblasts may be a useful intermediate phenotype to study genetic aspects of the metabolic syndrome.

UR - http://www.scopus.com/inward/record.url?scp=13844266007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844266007&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2004.10.003

DO - 10.1016/j.metabol.2004.10.003

M3 - Article

C2 - 15736115

AN - SCOPUS:13844266007

VL - 54

SP - 370

EP - 375

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 3

ER -